Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
14,640.00    100.00 (0.69%)
Bid:
14,600.00
Ask:
14,640.00
Spread: 40.00 (0.274%)
Market Cap: £1.12b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

Acquisition

23 Mar 2007 09:15

Goodwin PLC23 March 2007 Goodwin PLC ("Goodwin" or the "Company") 23 March 2007 ACQUISITION OF NOREVA GmbH Goodwin, the mechanical and refractory engineering group, announces theacquisition of 75% of the share capital of Noreva GmbH ("Noreva"), amanufacturer of non return nozzle check valves located in Monchengladbach,Germany for an initial consideration of £2.8 million in cash. In the year to 31 December 2006 Noreva generated turnover of Eur 7.3 million (£5 million), profit before tax of Eur 0.42 million (£0.288 million) and has gross assets of Eur 4.3 million (£2.9 million) audited. The remaining 25% share interest, which is owned equally by the two currentManaging Directors of Noreva, Messrs R. Kurzenberg and M. Sattelberg (the"Managing Directors"), who are to continue to serve Noreva in their presentcapacity following the acquisition, is subject to put options exercisable by the Managing Directors no sooner than 5 years, and a call option exercisable byGoodwin PLC no earlier than 12 years, from the date of completion of theacquisition. The initial consideration is £2.8 million in cash, together with £0.6 millionpayable to Noreva (i.e. funds retained within the Goodwin group) for a perpetualtechnology licence. A deferred consideration of an additional £1.0 million willbe paid in two instalments, payable after three and five years after completion,respectively. The consideration in case of the exercise of the put and/or calloption will be either £1.0 million for the remaining 25 % of the Novera sharesor is to be calculated based on 10 times annual average pre-tax profit of Noreva for three years prior to the exercise of the option, or a combination of both calculation methods, depending on, inter alia, the term of service of therespective Managing Director. The Company believes that Noreva is a complementary business and anticipatessignificant value being created from the excellent synergy in the marketing andproduction capacity opportunities between Noreva and Goodwin's UK basedsubsidiaries Goodwin International Ltd and Goodwin Steel Castings Ltd (the"Goodwin Companies"). The Goodwin Companies manufacture and supply dual platenon-return check valves for the oil and gas industry worldwide, whereas Norevasupplies a complementary but more costly and faster-acting nozzle check valve to applications requiring less backflow and pressure surge. Noreva and the Goodwin Companies will continue to benefit from each others'technology and marketing resources, which are also complementary. Financing fromGoodwin will enable Noreva to extend its facility in Monchengladbach and anagreed cooperation in the area of distribution will enable each company toreduce lead times and provide a faster service to their customers and achieveincreased sales. The acquisition of Noreva will enable the Goodwin Companies and Noreva tofurther strengthen their relative market positions through the ability to offercomplete check valve solutions to their principal markets in the hydrocarbon,processing and water industries. Francis Gaffney, Director and General Manager of Goodwin International Ltd anda main board director of Goodwin PLC, will become a Managing Director of Noreva,together with the existing Managing Directors. Enquiries: John GoodwinTel: +44 1782 220000Goodwin PLC END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Mar 20269:19 amRNSTrading Update
16th Dec 20257:00 amRNSHalf-year Report
18th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 20257:00 amRNSPLACING OF SHARES IN GOODWIN PLC
27th Oct 20257:00 amRNSTrading Update
1st Oct 20253:56 pmRNSResult of AGM
24th Sep 20258:16 amRNSTrading Update & Strategic Collaboration Agreement
14th Aug 202511:42 amRNSPosting of Annual Report and Accounts
30th Jul 20257:00 amRNSPreliminary results for the year ended 30 Apr 2025
12th May 20257:00 amRNSChanges to the Audit Committee
9th Apr 202511:00 amRNSDirector/PDMR Shareholding
19th Mar 20258:00 amRNSMarch 2025 Trading Update
18th Feb 20258:49 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSHalf-year Report
7th Oct 20247:00 amRNSAppointment of Joint Corporate Broker
2nd Oct 20243:03 pmRNSResult of AGM
25th Sep 202410:32 amRNSSeptember 2024 Trading Update
22nd Aug 20243:35 pmRNSPosting of Annual Report and Accounts
7th Aug 20247:00 amRNSPreliminary results for the year ended 30 Apr 2024
3rd Jul 20246:00 pmRNSSmurfit Kappa Group - Update
3rd Jun 20244:21 pmRNSDirector/PDMR Shareholding
15th Apr 20243:02 pmRNSDirector/PDMR Shareholding
28th Mar 20242:12 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSMarch 2024 Trading Update
20th Dec 20237:00 amRNSHalf-year Report
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20233:12 pmRNSDirector/PDMR Shareholding
29th Aug 20234:02 pmRNSPosting of Annual Report and Accounts
8th Aug 20237:00 amRNSPreliminary results for the year ended 30 Apr 2023
30th Jun 20237:00 amRNSTotal Voting Rights
5th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSResult of Tender Offer, TVR & Directors' interests
30th May 20232:39 pmRNSResult of General Meeting
5th May 20231:05 pmRNSProposed Tender Offer
3rd Apr 20237:00 amRNSDirector Retirement
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
22nd Dec 202210:34 amRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSHalf-year Report
22nd Nov 20224:35 pmRNSPrice Monitoring Extension
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20222:54 pmRNSResult of AGM
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
19th Aug 20222:38 pmRNSPosting of Annual Report and Accounts
3rd Aug 20227:00 amRNSFinal Results
6th Apr 202212:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSHalf-year Report
18th Oct 20214:07 pmRNSDirector/PDMR Shareholding
15th Oct 20214:40 pmRNSSecond Price Monitoring Extn
15th Oct 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.